Certolizumab pegol induced paradoxical psoriatic alopecia with therapeutic response to bimekizumab
Anais Brasileiros de Dermatologia · 2026-03 · 101 (2) · 501320
DOI: 10.1016/j.abd.2026.501320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anais Brasileiros de Dermatologia, 2026-03. Verfasst von Gamze Taş Aygar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Ankara Etlik City Hospital, Ankara, Turkey. Electronic address: gamze_0890@hotmail.com. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, Ankara Etlik City Hospital, Ankara, Turkey. Electronic address: gamze_0890@hotmail.com.
- Department of Dermatology, Ankara Etlik City Hospital, Ankara, Turkey.
- Department of Pathology, Ankara Etlik City Hospital, Ankara, Turkey.
Zitieren
APA
Taş Aygar, G., Keleş, F., Biber, F. E., Han, U., & Kartal, S. P. (2026). Certolizumab pegol induced paradoxical psoriatic alopecia with therapeutic response to bimekizumab. Anais Brasileiros de Dermatologia, 101(2), 501320. https://doi.org/10.1016/j.abd.2026.501320
Vancouver
Taş Aygar G, Keleş F, Biber FE, Han U, Kartal SP. Certolizumab pegol induced paradoxical psoriatic alopecia with therapeutic response to bimekizumab. Anais Brasileiros de Dermatologia. 2026;101(2):501320. doi:10.1016/j.abd.2026.501320
BibTeX
@article{TaAygar2026,
author = {Taş Aygar, Gamze and Keleş, Furkan and Biber, Feyzanur Elif and Han, Unsal and Kartal, Selda Pelin},
title = {Certolizumab pegol induced paradoxical psoriatic alopecia with therapeutic response to bimekizumab},
journal = {Anais Brasileiros de Dermatologia},
year = {2026},
volume = {101},
number = {2},
pages = {501320},
doi = {10.1016/j.abd.2026.501320}
}
EUVIMED